Invention Grant
- Patent Title: Therapeutic agents for regulating serum phosphorus
- Patent Title (中): 用于调节血清磷的治疗剂
-
Application No.: US13492778Application Date: 2012-06-08
-
Publication No.: US08969299B2Publication Date: 2015-03-03
- Inventor: Felix Karim , Gregory Bell
- Applicant: Felix Karim , Gregory Bell
- Applicant Address: US CA South San Francisco
- Assignee: KAI Pharmaceuticals, Inc.
- Current Assignee: KAI Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDermott Will & Emery LLP
- Main IPC: C07K7/06
- IPC: C07K7/06 ; A61K38/08 ; A61K45/06

Abstract:
Methods for modulating serum phosphorus levels are described, wherein calcimimetic agents are administered to a subject in need thereof. In one embodiment, the compound is cinacalcet, and in other embodiments the compound is comprised of a contiguous sequence of subunits, X1—X2—X3—X4—X5—X6—X7, wherein the X1 subunit comprises a thiol-containing moiety and the distribution of charge on the X2-X7 subunits. The compound, when administered at selected times to a patient undergoing dialysis, lowers serum phosphorus levels, relative to pre-dosing levels, and achieves a sustained reduced level for a period of time after administration.
Public/Granted literature
- US20130150301A1 THERAPEUTIC AGENTS FOR REGULATING SERUM PHOSPHORUS Public/Granted day:2013-06-13
Information query